The PLOS ONE Editors retract this article [1, 2] because it was identified as one of a series of submissions for which we have concerns about authorship, competing interests, and peer review. We regret that the issues were not addressed prior to the article’s publication.
All authors did not agree with the retraction.
References
- 1. Noor F, Saleem MH, Chen J-T, Javed MR, Al-Megrin WA, Aslam S (2021) Integrative bioinformatics approaches to map key biological markers and therapeutic drugs in Extramammary Paget’s disease of the scrotum. PLoS ONE 16(7): e0254678. https://doi.org/10.1371/journal.pone.0254678 pmid:34292991
- 2. Noor F, Saleem MH, Chen J-T, Javed MR, Al-Megrin WA, Aslam S (2021) Correction: Integrative bioinformatics approaches to map key biological markers and therapeutic drugs in Extramammary Paget’s disease of the scrotum. PLoS ONE 16(10): e0259408. https://doi.org/10.1371/journal.pone.0259408 pmid:34705874
Citation: The PLOS ONE Editors (2022) Retraction: Integrative bioinformatics approaches to map key biological markers and therapeutic drugs in Extramammary Paget’s disease of the scrotum. PLoS ONE 17(8): e0273532. https://doi.org/10.1371/journal.pone.0273532
Published: August 31, 2022
Copyright: © 2022 The PLOS ONE Editors. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.